Thomas Hamilton's most recent trade in Annaly Capital Management Inc was a trade of 8,583 Deferred Stock Units done . Disclosure was reported to the exchange on May 15, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Annaly Capital Management Inc
|
Thomas Edward Hamilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 8,583 | 36,282 | - | - | Deferred Stock Units | |
Larimar Therapeutics Inc
|
Thomas Edward Hamilton | Director | Purchase of securities on an exchange or from another person at price $ 8.74 per share. | 16 Feb 2024 | 57,208 | 564,798 | - | 8.7 | 499,998 | Common Stock |
Larimar Therapeutics Inc
|
Thomas Edward Hamilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
Annaly Capital Management Inc
|
Thomas Edward Hamilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 8,167 | 27,698 | - | - | Deferred Stock Units | |
Larimar Therapeutics Inc
|
Thomas Edward Hamilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2023 | 8,300 | 8,300 | - | - | Stock Option (Right to Buy) | |
Larimar Therapeutics Inc
|
Thomas Edward Hamilton | Director | Purchase of securities on an exchange or from another person at price $ 3.15 per share. | 16 Sep 2022 | 317,460 | 507,590 | - | 3.2 | 999,999 | Common Stock |
Annaly Capital Management Inc
|
Thomas Edward Hamilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 24,372 | 78,124 | - | - | Deferred Stock Units | |
Larimar Therapeutics Inc
|
Thomas Edward Hamilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2022 | 8,300 | 8,300 | - | - | Stock Option (Right to Buy) | |
Larimar Therapeutics Inc
|
Thomas Edward Hamilton | Director | Purchase of securities on an exchange or from another person at price $ 8.75 per share. | 30 Jun 2021 | 56,710 | 190,130 | - | 8.8 | 496,213 | Common Stock |
Annaly Capital Management Inc
|
Thomas Edward Hamilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2021 | 15,609 | 53,752 | - | - | Deferred Stock Units | |
Larimar Therapeutics Inc
|
Thomas Edward Hamilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 8,300 | 8,300 | - | - | Stock Option (right to buy) | |
Annaly Capital Management Inc
|
Thomas Edward Hamilton | Director | Sale of securities on an exchange or to another person at price $ 9.18 per share. | 03 May 2021 | 80,000 | 0 (0%) | 0% | 9.2 | 734,432 | Common Stock |
Larimar Therapeutics Inc
|
Thomas Hamilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2020 | 16,600 | 16,600 | - | - | Stock Option (right to buy) | |
Larimar Therapeutics Inc
|
Thomas Hamilton | Director | Other type of transaction at price $ 0.00 per share. | 26 Jun 2020 | 159,433 | 292,853 | - | 0 | Common Stock | |
Larimar Therapeutics Inc
|
Thomas Hamilton | Director | Other type of transaction at price $ 0.00 per share. | 26 Jun 2020 | 133,420 | 133,420 | - | 0 | Common Stock | |
Annaly Capital Management Inc
|
Thomas Hamilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2020 | 22,551 | 38,143 | - | - | Deferred Stock Units | |
Annaly Capital Management Inc
|
Thomas Hamilton | Director | Purchase of securities on an exchange or from another person at price $ 5.96 per share. | 15 May 2020 | 200,000 | 330,000 (0%) | 0% | 6.0 | 1,192,920 | Common Stock |